Physician profile
Amanda Cox
NPI 1831879428
$855.62
in general payments reported to CMS, 2019-2025
9 companies · $408 in 2025
The $408 reported for 2025 was more than what 96% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $447 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $755.63 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $479.00 | 2024-2025 | Rybrevant, Darzalex, Talvey |
| Merck Sharp & Dohme LLC | $156.80 | 2024-2025 | Bridion |
| Tersera Therapeutics LLC | $62.71 | 2024-2025 | Zoladex, Xermelo |
| Medline Industries Lp | $41.93 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $37.58 | 2024-2025 | Exparel |
| Takeda Pharmaceuticals U.S.A., INC. | $24.60 | 2024 | Alunbrig |
| Olympus America INC. | $20.85 | 2025 | |
| Chiesi USA, INC. | $16.15 | 2024 | Cleviprex |
| Draeger Medical Systems, INC | $16.00 | 2025 | Atlan A350 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.